Vito Lepore Selected Research

Vito Lepore Research Topics

6	Multiple Sclerosis 04/2024 - 04/2007
3	Heart Failure 01/2022 - 01/2018
2	Neoplasms (Cancer) 03/2022 - 09/2006
2	Relapsing-Remitting Multiple Sclerosis 02/2022 - 04/2007
2	Diabetes Mellitus 01/2022 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2015
1	Chronic Progressive Multiple Sclerosis 05/2024
1	Progressive Multifocal Leukoencephalopathy 02/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	COVID-19 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Infections 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Sudden Infant Death (SID) 12/2020
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2015
1	Stillbirth 01/2015
1	Cerebral Hemorrhage 06/2012
1	Hemorrhage 06/2012
1	Hypertension (High Blood Pressure) 05/2009
1	Disease Progression 04/2007
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2006

5	Natalizumab (Tysabri)FDA Link 05/2024 - 11/2015
3	Interferon-betaIBA 01/2022 - 04/2007
2	nitazoxanide (NTZ)FDA Link 02/2022 - 12/2020
2	Insulin (Novolin)FDA Link 01/2022 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2015
2	insulin receptor-related receptor (IRR)IBA 01/2015 - 06/2012
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	Glatiramer Acetate (Copaxone)FDA Link 11/2015
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2015
1	SuspensionsIBA 11/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2012
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2009
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2006

5	Therapeutics 04/2024 - 05/2009